Sharon X. Liang

5.5k total citations · 1 hit paper
57 papers, 3.2k citations indexed

About

Sharon X. Liang is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Sharon X. Liang has authored 57 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Obstetrics and Gynecology, 24 papers in Reproductive Medicine and 15 papers in Molecular Biology. Recurrent topics in Sharon X. Liang's work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Sarcoma Diagnosis and Treatment (8 papers). Sharon X. Liang is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Sarcoma Diagnosis and Treatment (8 papers). Sharon X. Liang collaborates with scholars based in United States, China and Canada. Sharon X. Liang's co-authors include Benjamin E. Greer, Robert A. Burger, Howard D. Homesley, Jeffrey M. Fowler, Bradley J. Monk, Matthew Boente, Robert S. Mannel, Helen Huang, Gini F. Fleming and Mark F. Brady and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sharon X. Liang

56 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

2011 1.6k citations Robert A. Burger, Mark F. Brady et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon X. Liang United States	24	2.0k	1.1k	914	893	655	57	3.2k
Michael Teneriello United States	17	1.6k 0.8×	1.1k 1.0×	487 0.5×	512 0.6×	535 0.8×	33	2.3k
Kosei Hasegawa Japan	26	940 0.5×	1.4k 1.3×	678 0.7×	1.0k 1.1×	486 0.7×	179	3.0k
Shoji Kodama Japan	20	1.5k 0.7×	806 0.8×	474 0.5×	900 1.0×	473 0.7×	40	2.6k
Matthew F. Kohler United States	23	929 0.5×	804 0.8×	801 0.9×	939 1.1×	324 0.5×	57	2.5k
Tsui-Lien Mao Taiwan	25	1.4k 0.7×	574 0.5×	2.0k 2.2×	513 0.6×	256 0.4×	31	3.2k
Ruth Perets Israel	18	613 0.3×	1.3k 1.2×	914 1.0×	394 0.4×	414 0.6×	61	2.7k
Patricia A. Shaw Canada	29	1.4k 0.7×	1.1k 1.0×	976 1.1×	348 0.4×	155 0.2×	57	3.0k
Christian Kurzeder Germany	25	1.0k 0.5×	709 0.7×	363 0.4×	494 0.6×	589 0.9×	88	2.0k
Uziel Beller Israel	25	803 0.4×	723 0.7×	971 1.1×	356 0.4×	411 0.6×	68	3.0k
Birthe Lund Denmark	22	782 0.4×	1.1k 1.0×	640 0.7×	257 0.3×	623 1.0×	73	2.3k

Countries citing papers authored by Sharon X. Liang

Since Specialization

Citations

This map shows the geographic impact of Sharon X. Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon X. Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon X. Liang more than expected).

Fields of papers citing papers by Sharon X. Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon X. Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon X. Liang. The network helps show where Sharon X. Liang may publish in the future.

Co-authorship network of co-authors of Sharon X. Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon X. Liang. A scholar is included among the top collaborators of Sharon X. Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon X. Liang. Sharon X. Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xing, Deyin, et al.. (2023). Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract. Modern Pathology. 36(1). 100031–100031. 4 indexed citations

Hacking, Sean, et al.. (2019). PD-L1/PD-1 Expression in Endometrial Clear Cell Carcinoma: A Potential Surrogate Marker for Clinical Trials. International Journal of Surgical Pathology. 28(1). 31–37. 6 indexed citations

Fadare, Oluwole, Mohamed Mokhtar Desouki, Katja Gwin, et al.. (2017). Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases. International Journal of Gynecological Pathology. 37(6). 525–535. 6 indexed citations

Fadare, Oluwole, Mohamed Mokhtar Desouki, Katja Gwin, et al.. (2013). Frequent Expression of Napsin A in Clear Cell Carcinoma of the Endometrium. 49 indexed citations

Burger, Robert A., Mark F. Brady, Michael A. Bookman, et al.. (2012). Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer. Obstetrical & Gynecological Survey. 67(5). 289–290. 197 indexed citations

Karaayvaz, Mihriban, et al.. (2012). Prognostic Significance of miR-205 in Endometrial Cancer. PLoS ONE. 7(4). e35158–e35158. 91 indexed citations

Fadare, Oluwole & Sharon X. Liang. (2012). Diagnostic Utility of Hepatocyte Nuclear Factor 1-Beta Immunoreactivity in Endometrial Carcinomas. Applied immunohistochemistry & molecular morphology. 20(6). 580–587. 59 indexed citations

Monk, Bradley J., Helen Huang, Robert A. Burger, et al.. (2012). Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: A Gynecologic Oncology Group Study. Gynecologic Oncology. 128(3). 573–578. 49 indexed citations

Fadare, Oluwole, et al.. (2012). Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment. Journal of Cancer. 3. 129–136. 41 indexed citations

10.

Fadare, Oluwole, et al.. (2011). The Phosphatidylinositol 3′ Kinase-Akt-mammalian Target of Rapamycin Pathway in Smooth Muscle Tumors of the Uterus. International Journal of Gynecological Pathology. 33(3). 244–251. 2 indexed citations

11.

Fadare, Oluwole, et al.. (2011). Patterns of Bone Morphogenetic Protein-2 Expression in Smooth Muscle Tumors of the Uterine Corpus and Other Uterine Tissues. Applied immunohistochemistry & molecular morphology. 19(4). 352–359. 4 indexed citations

12.

Mazella, James, et al.. (2009). Notch ligand-dependent gene expression in human endometrial stromal cells. Biochemical and Biophysical Research Communications. 388(3). 479–482. 34 indexed citations

13.

Zhang, Xi, Sharon X. Liang, Lin Jia, et al.. (2009). Molecular Identification of “Latent Precancers” for Endometrial Serous Carcinoma in Benign-Appearing Endometrium. American Journal Of Pathology. 174(6). 2000–2006. 23 indexed citations

14.

Fadare, Oluwole, Malaiyalam Mariappan, Jonathan L. Hecht, et al.. (2008). A Comparative Analysis of Lymphatic Vessel Density in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors) With and Without Lymph Node Involvement. International Journal of Gynecological Pathology. 27(4). 483–490. 12 indexed citations

15.

Simon, Rochelle A., Paul A. di Sant'Agnese, Li‐Shan Huang, et al.. (2008). CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers. Human Pathology. 40(2). 252–258. 60 indexed citations

16.

Liang, Sharon X., et al.. (2008). "Malignant" Uterine Perivascular Epithelioid Cell Tumor, Pelvic Lymph Node Lymphangioleiomyomatosis, and Gynecological Pecomatosis in a Patient With Tuberous Sclerosis. International Journal of Gynecological Pathology. 27(1). 86–90. 41 indexed citations

17.

Liang, Sharon X., et al.. (2007). Sertoliform Endometrioid Carcinoma of the Endometrium With Dual Immunophenotypes for Epithelial Membrane Antigen and Inhibin ??. International Journal of Gynecological Pathology. 26(3). 291–297. 10 indexed citations

18.

Zheng, Wenxin, Sharon X. Liang, Xiaofang Yi, et al.. (2006). Occurrence of Endometrial Glandular Dysplasia Precedes Uterine Papillary Serous Carcinoma. International Journal of Gynecological Pathology. 26(1). 38–52. 30 indexed citations

19.

Zheng, Wenxin, Sharon X. Liang, Herbert Yu, et al.. (2004). Endometrial Glandular Dysplasia: A Newly Defined Precursor Lesion of Uterine Papillary Serous Carcinoma. Part I: Morphologic Features. International Journal of Surgical Pathology. 12(3). 207–223. 59 indexed citations

20.

Zhao, Jin, Sharon X. Liang, Lou Savas, & Barbara F. Banner. (2001). An Immunostaining Panel for Diagnosis of Malignancy in Mucinous Tumors of the Pancreas. Archives of Pathology & Laboratory Medicine. 125(6). 765–769. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact